NLRP3 and peritonitis: The study further suggested that the therapeutic effect of wedelolactone on MSU-induced peritonitis and GA is partially achieved by enhancing the PKA signaling pathway and further promoting the Ser/Thr phosphorylation of NLRP3 (86).